Cannimed Ltd. | First Medical Marijuana Clinical Trial Registered With Health Canada

These receptors respond to the cannabinoids found in medical marijuana, similar to how a key opens a lock. Medical marijuana research has demonstrated its efficacy at reducing pain when used by itself or in combination with other pain-relievers. Many cases of anecdotal evidence have been reported for arthritis patients who have very successfully used medical marijuana either in conjunction with traditional therapy or alone. “Well designed controlled trials are needed to answer many of the claims made around medical cannabis,” says Dr. Mark Ware, executive director of the Canadian Consortium for the Investigation of Cannabinoids (CCIC) and a practicing pain physician at the McGill University Health Centre. “We are continually looking for options to help treat patients who do not respond to traditional pharmacotherapy. Research of this kind will start answering some important questions about dose and efficacy, use of vapourization as a delivery system in clinical practice, and hopefully will encourage other licensed producers to join in the research endeavours.” For the 4.6 million Canadians with arthritis, anti-inflammatory and analgesic medications are the only current options available for symptom management. While effective for the majority of patients, there are some cases where current medication just isn’t enough to control the pain and inflammation. “We know that many people living with arthritis actively seek alternative options for pain relief,” said Joanne Simons, chief mission officer, The Arthritis Society. “Knowing that, we are very pleased to see that a clinical trial specific to osteoarthritis of the knee has been registered with Health Canada. Clinical research is the necessary first step to get us to where we want to go: more treatment options available for the arthritis community.” About CanniMed Ltd.
For the original version including any supplementary images or video, visit

Comments are closed.